Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Bayer Regorafenib Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.